Anzeige
Mehr »
Login
Samstag, 22.02.2025 Börsentäglich über 12.000 News von 688 internationalen Medien
851 % Rendite in 30 Tagen: Die KI-Aktie, die seit der Integration von Deepseek R1 Wellen schlägt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PharmaTimes

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
18.09.24FlyPharma Europe, Vienna - October 2024 conference
17.09.24UKRI's MRC awards £27.4m to University of Dundee research unit
16.09.24WHO adds first mpox vaccine to prequalification list
13.09.24World Sepsis Day 2024 highlights need for better sepsis treatments
13.09.24Nxera and Cancer Research UK to present promising cancer drug trial at ESMO
12.09.24HRT linked to reduced psychosis relapse risk in menopausal women
12.09.24Centessa reports positive phase 1 clinical data for ORX750
11.09.24Scotland first in UK to approve new myeloma treatment
11.09.24AI-Powered chest X-Rays detect lung cancer early
10.09.24Phase 2 PREDICT-ILD imaging study commences in interstitial lung disease
10.09.24APL and CurifyLabs partner to support patients with 3D printing medicine technology
09.09.24ChatGPT outperforms trainee doctors in assessing respiratory illness in children
06.09.24Eli Lilly's once-weekly insulin shows promise in phase 3 trials
05.09.24AMBLor prognostic melanoma biomarker receives UKCA Mark
05.09.24European Commission grants orphan drug designation for Vivet's VTX-806
28.08.24Acelyrin's izokibep for hidradenitis suppurativa reveals positive results
28.08.24myTomorrows and Pancreatic Cancer Europe partner on clinical trials
27.08.24National campaign launches to end prostate cancer postcode lottery
27.08.24Improving tracking of AMR bacteria in hospitals using new genomic technique